International Cannabis Corp. (ICC) is the first licensed integrated cannabis corporation in South America – producing, researching and marketing cannabis for medical and recreational uses.
ICC owns the largest legal cannabis fields in South America making it a leader in the development of cannabis and hemp products.
Doing business in one of South America’s most business friendly jurisdictions – Uruguay
Uruguay has positioned itself as an attractive and reliable destination for foreign investors as a result of a long-term business friendly environment with political stability and good macroeconomic performance.
The environmental conditions offered are very attractive for the development of cannabis production and agribusiness in general.
Uruguay ranks near the top of Latin American countries for political stability and ease of doing business. It has a favorable legal framework that provides the broadest guarantees and clear rules of the game.
The Economist named Uruguay "country of the year" in 2013, acknowledging the innovative policy of legalizing the production, sale and consumption of cannabis.
In addition, more than 620 million people living in South America make Uruguay a strategically important location for ICC where it benefits from international agreements (Mercosur among others) within the region.
The potential benefits of cannabis for medical and pharmaceutical treatments are still being discovered. Increasing our knowledge of the product, its properties and applications is an essential part of the ICC strategy. For this reason, ICC is making a substantial investment in pioneering cannabis research to improve understanding of its physical uses and medical benefits. Our impressive land package, consisting of more than 4 million square feet of licensed acreage, also lends itself to allowing strategic research alliances with a view to developing valuable intellectual property and opening ICC up to potential licensing opportunities.
ICC is committed to protecting the environment, sustainably cultivating and crafting every product to the highest ethical and biological standards.
Our impressive land package, consisting of more than 4 million square feet of licensed acreage, also lends itself to allowing strategic research alliances with a view to developing valuable intellectual property and opening ICC up to potential licensing opportunities.